Wolverine Trading, LLC Alnylam Pharmaceuticals, Inc. Transaction History

Wolverine Trading, LLC

$93.9 Billion
Q3 2024

A detailed history of Wolverine Trading, LLC transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Wolverine Trading, LLC holds 16,700 shares of ALNY stock, worth $4.24 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

16,700

Previous 45,000 62.89%

Holding current value

$4.24 Million

Previous $10.9 Million 58.0%

% of portfolio

0.0%

Previous 0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$151.41 - $196.57 $446,053 - $579,095	2,946 New	2,946 $563,000
Q4 2022 Feb 14, 2023	BUY	$185.53 - $241.31 $245,456 - $319,253	1,323 New	1,323 $314,000
Q2 2022 Aug 15, 2022	BUY	$120.42 - $169.29 $171,598 - $241,238	1,425 Added 90.65%	2,997 $436,000
Q1 2022 May 16, 2022	SELL	$127.18 - $173.91 $261,227 - $357,211	-2,054 Reduced 56.65%	1,572 $260,000
Q4 2021 Feb 14, 2022	BUY	$159.56 - $209.29 $236,467 - $310,167	1,482 Added 69.12%	3,626 $620,000
Q3 2021 Nov 12, 2021	SELL	$169.75 - $207.73 $784,584 - $960,128	-4,622 Reduced 68.31%	2,144 $380,000
Q2 2021 Aug 06, 2021	BUY	$128.63 - $176.89 $307,940 - $423,474	2,394 Added 54.76%	6,766 $1.12 Million
Q1 2021 May 14, 2021	BUY	$126.83 - $175.69 $122,010 - $169,013	962 Added 28.21%	4,372 $591,000
Q4 2020 Feb 12, 2021	SELL	$122.97 - $147.0 $249,629 - $298,410	-2,030 Reduced 37.32%	3,410 $447,000
Q4 2019 Feb 12, 2020	SELL	$74.51 - $124.23 $142,761 - $238,024	-1,916 Reduced 26.05%	5,440 $624,000
Q2 2019 Aug 20, 2019	SELL	$65.86 - $92.79 $412,415 - $581,050	-6,262 Reduced 45.98%	7,356 $534,000
Q4 2018 Feb 14, 2019	SELL	$62.67 - $88.33 $805,936 - $1.14 Million	-12,860 Reduced 48.57%	13,618 $959,000
Q3 2018 Nov 14, 2018	BUY	$87.52 - $122.67 $1.42 Million - $1.99 Million	16,190 Added 157.37%	26,478 $2.32 Million
Q4 2017 Feb 14, 2018	BUY	$114.49 - $139.98 $1.18 Million - $1.44 Million	10,288	10,288 $1.31 Million

Others Institutions Holding ALNY

# of Institutions

644

Shares Held

109M

Call Options Held

1.28M

Put Options Held

1.21M

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $31.2B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account

Wolverine Trading, LLC Alnylam Pharmaceuticals, Inc. Transaction History